BRIEF-Clinuvel Pharmaceuticals Says Philippe Wolgen Returns As MD

Reuters
13 Jun
BRIEF-Clinuvel Pharmaceuticals Says Philippe Wolgen Returns As MD

June 13 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX:

  • PHILIPPE WOLGEN RETURNS AS MANAGING DIRECTOR

  • LACHLAN HAY TO CONTINUE AS ACTING CEO UNTIL SEPTEMBER 2025

Further company coverage: CUV.AX

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10